Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer

NCT03851497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2021-03-26

No results posted yet for this study

Summary

As the most common cancer expected to occur all over the world, breast cancer still faces with the unsatisfied diagnostic accuracy in US imaging. S-detect is a sophisticated CAD system for breast US imaging based on deep learning algorithms. E-breast is a software installed in US machines which automatically reveals tumor elastographic features. This multi-center study intends to further validate the diagnostic efficiency of S-detect and E-breast in opportunistic breast cancer screening populations in China. Our hypothesis is that S-detect and E-breast can increase the diagnostic accuracy and specificity as compared to routinely US examinations by doctors.

Conditions

Sponsors & Collaborators

  • Peking University Third Hospital

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Beijing Zhongguancun Hospital

    collaborator UNKNOWN
  • Peking University Aerospace Center Hospital

    collaborator OTHER
  • Beijing Anzhen Community Health Service Center

    collaborator UNKNOWN
  • First Hospital of Tsinghua University

    collaborator OTHER
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Third Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Xinxiang Central Hospital

    collaborator OTHER
  • Henan Cancer Hospital

    collaborator OTHER_GOV
  • First Hospital of China Medical University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Liaoning Cancer Hospital & Institute

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Sichuan Provincial People's Hospital

    collaborator OTHER
  • Yan'an Hospital of Kunming City

    collaborator UNKNOWN
  • Xi'an Central Hospital

    collaborator OTHER
  • Ningxia Medical University

    collaborator OTHER
  • First Hospital of Shijiazhuang City

    collaborator OTHER
  • Chengde Central Hospital

    collaborator OTHER_GOV
  • Qinghai Province Cancer Hospital

    collaborator UNKNOWN
  • Gansu Cancer Hospital

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Qingdao Central Hospital

    collaborator OTHER
  • Jining First People's Hospital

    collaborator OTHER
  • Linyi Tumour Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Second Hospital of Jilin University

    collaborator OTHER
  • The Second Hospital of the West Coast New Area of Qingdao

    collaborator UNKNOWN
  • Fudan University

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • Jiangsu Province People's Hospital

    collaborator UNKNOWN
  • Peking University Shougang Hospital

    collaborator OTHER
  • Gansu Jiugang Hospital

    collaborator UNKNOWN
  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03851497 on ClinicalTrials.gov